Literature DB >> 17822370

Role of redox reactions in the vascular phenotype of hyperhomocysteinemic animals.

Sanjana Dayal1, Steven R Lentz.   

Abstract

Hyperhomocysteinemia is a risk factor for cardiovascular disease, stroke, and thrombosis. Several animal models of hyperhomocysteinemia have been developed by using both dietary and genetic approaches. These animal models have provided considerable insight into the mechanisms underlying the adverse vascular effects of hyperhomocysteinemia. Accumulating evidence suggests a significant role of altered cellular redox reactions in the vascular phenotype of hyperhomocysteinemia. Redox effects of hyperhomocysteinemia are particularly important in mediating the adverse effects of hyperhomocysteinemia on the endothelium, leading to loss of endothelium-derived nitric oxide and vasomotor dysfunction. Redox reactions also may be key factors in the development of vascular hypertrophy, thrombosis, and atherosclerosis in hyperhomocysteinemic animals. In this review, we summarize the metabolic relations between homocysteine and the cellular redox state, the vascular phenotypes that have been observed in hyperhomocysteinemic animals, the evidence for altered redox reactions in vascular tissue, and the specific redox reactions that may mediate the vascular effects of hyperhomocysteinemia.

Entities:  

Mesh:

Year:  2007        PMID: 17822370     DOI: 10.1089/ars.2007.1806

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  15 in total

1.  The homocysteine paradox.

Authors:  Roman N Rodionov; Steven R Lentz
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-06       Impact factor: 8.311

Review 2.  Homocysteine to hydrogen sulfide or hypertension.

Authors:  Utpal Sen; Paras K Mishra; Neetu Tyagi; Suresh C Tyagi
Journal:  Cell Biochem Biophys       Date:  2010-07       Impact factor: 2.194

3.  Vein graft disease in a knockout mouse model of hyperhomocysteinaemia.

Authors:  Christina Maria Steger; Tobias Mayr; Nikolaos Bonaros; Johannes Bonatti; Thomas Schachner
Journal:  Int J Exp Pathol       Date:  2016-12-22       Impact factor: 1.925

Review 4.  Combined methylmalonic acidemia and homocystinuria, cblC type. II. Complications, pathophysiology, and outcomes.

Authors:  Nuria Carrillo-Carrasco; Charles P Venditti
Journal:  J Inherit Metab Dis       Date:  2011-07-12       Impact factor: 4.982

5.  Allicin improves carotid artery intima-media thickness in coronary artery disease patients with hyperhomocysteinemia.

Authors:  De-Shan Liu; Shu-Li Wang; Jun-Mei Li; Er-Shun Liang; Ming-Zhong Yan; Wei Gao
Journal:  Exp Ther Med       Date:  2017-06-28       Impact factor: 2.447

Review 6.  PPARalpha: an emerging therapeutic target in diabetic microvascular damage.

Authors:  Anne Hiukka; Marianna Maranghi; Niina Matikainen; Marja-Riitta Taskinen
Journal:  Nat Rev Endocrinol       Date:  2010-06-22       Impact factor: 43.330

7.  Tissue-specific downregulation of dimethylarginine dimethylaminohydrolase in hyperhomocysteinemia.

Authors:  Sanjana Dayal; Roman N Rodionov; Erland Arning; Teodoro Bottiglieri; Masumi Kimoto; Daryl J Murry; John P Cooke; Frank M Faraci; Steven R Lentz
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-06-20       Impact factor: 4.733

8.  Homocysteine-mediated thrombosis and angiostasis in vascular pathobiology.

Authors:  Joseph Loscalzo
Journal:  J Clin Invest       Date:  2009-10-19       Impact factor: 14.808

9.  Chronic diet-induced hyperhomocysteinemia impairs eNOS regulation in mouse mesenteric arteries.

Authors:  Robin C Looft-Wilson; Blair S Ashley; Janelle E Billig; Madeline R Wolfert; Lindsay A Ambrecht; Shawn E Bearden
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-04-30       Impact factor: 3.619

Review 10.  Murine models of hyperhomocysteinemia and their vascular phenotypes.

Authors:  Sanjana Dayal; Steven R Lentz
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-06-12       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.